The Sleeping Beauty transposon system: a non-viral vector for gene therapy

EL Aronovich, RS McIvor… - Human molecular …, 2011 - academic.oup.com
Over the past decade, the Sleeping Beauty (SB) transposon system has been developed as
the leading non-viral vector for gene therapy. This vector combines the advantages of …

[HTML][HTML] A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

P Boström, J Wu, MP Jedrychowski, A Korde, L Ye… - Nature, 2012 - nature.com
Exercise benefits a variety of organ systems in mammals, and some of the best-recognized
effects of exercise on muscle are mediated by the transcriptional co-activator PPAR-γ co …

Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy

PB Hackett, DA Largaespada, KC Switzer… - Translational …, 2013 - Elsevier
Investigational therapy can be successfully undertaken using viral-and nonviral-mediated ex
vivo gene transfer. Indeed, recent clinical trials have established the potential for genetically …

Synergetic targeted delivery of sleeping‐beauty transposon system to mesenchymal stem cells using LPD nanoparticles modified with a phage‐displayed targeting …

K Ma, DD Wang, Y Lin, J Wang… - Advanced functional …, 2013 - Wiley Online Library
An important criterion for effective gene therapy is sufficient chromosomal integration activity.
The Sleeping Beauty (SB) transposon system is a plasmid system allowing efficient insertion …

Recent developments in transposon-mediated gene therapy

M Di Matteo, E Belay, MK Chuah… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: The continuous improvement of gene transfer technologies has broad
implications for stem cell biology, gene discovery, and gene therapy. Although viral vectors …

Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies

P B. Hackett, E L. Aronovich, D Hunter… - Current gene …, 2011 - benthamdirect.com
Sleeping Beauty (SB) transposons have been effective in delivering therapeutic genes to
treat certain diseases in mice. Hydrodynamic gene delivery of integrating transposons to 5 …

Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti‐cancer therapy

HL Ju, KH Han, JD Lee, SW Ro - International journal of cancer, 2016 - Wiley Online Library
Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide; however, the
genetic mechanisms underlying its pathogenesis are incompletely understood. Genetically …

Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging

HL Ju, SH Ahn, DY Kim, S Baek, SI Chung, J Seong… - PLoS …, 2013 - journals.plos.org
Liver cancer is a complex multistep process requiring genetic alterations in multiple proto-
oncogenes and tumor suppressor genes. Although hundreds of genes are known to play …

Prolonged activity of the transposase helper may raise safety concerns during DNA transposon-based gene therapy

G Imre, B Takács, E Czipa, AB Drubi, G Jaksa… - … Therapy Methods & …, 2023 - cell.com
DNA transposon-based gene delivery vectors represent a promising new branch of
randomly integrating vector development for gene therapy. For the side-by-side evaluation …

Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse model

V Chiu, C Yee, N Main, I Stevanovski, M Watt… - Clinical …, 2024 - portlandpress.com
Primary liver cancer is an increasing problem worldwide and is associated with significant
mortality. A popular method of modeling liver cancer in mice is plasmid hydrodynamic tail …